Fontanet B.
- Country
- France
- Department
- Hematology
Research Overview
- A Study of CC-122 in Patients with Multiple Myeloma, Follicular Lymphoma, and Diffuse Large B-Cell Lymphoma
- Efficacy and Safety Evaluation of Glofitamab with Gemcitabine and Oxaliplatin Versus Rituximab in Relapsed/Refractory Diffuse Large B-Cell Lymphoma
- Phase 2 Study on Zanubrutinib and BGB-11417 Efficacy and Tolerance in Previously Treated Waldenström Macroglobulinemia Patients
Data & Insights
Has run more than one trial at 206 of 395 partner sites.
Specializations
B-Cell Lymphoma Research
The investigator specializes in treating various forms of B-cell lymphomas, with particular emphasis on diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma. Their research extends to both newly diagnosed and relapsed/refractory cases.
- Large B-cell lymphoma treatments
- Novel combination therapies
- CD20-expressing lymphomas
Specialized Lymphoma Studies
The investigator focuses on rare and specific lymphoma subtypes including mantle cell lymphoma, marginal zone lymphoma, and peripheral T-cell lymphoma. Their work encompasses innovative therapeutic approaches for these distinct conditions.
- Targeted molecular therapies
- Immunotherapy approaches
- Treatment resistance mechanisms
Advanced Treatment Modalities
The investigator explores cutting-edge treatment combinations incorporating monoclonal antibodies, BTK inhibitors, and novel therapeutic agents. Their research includes evaluation of maintenance therapy strategies and treatment optimization for various lymphoma subtypes.
- Combination therapy development
- Treatment sequencing strategies
- Novel drug applications
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.